Navigation Links
Hospira Supports Disaster Relief Efforts in Haiti With Products and Cash Grants

LAKE FOREST, Ill., Jan. 22 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, and its philanthropic arm, the Hospira Foundation, have made initial donations of approximately $1.75 million in medical products and cash grants to support humanitarian relief efforts in Haiti. More than 750,000 units of Hospira products, valued at more than $1.5 million, are either in Haiti or en route to the country and include antibiotics, intravenous (I.V.) solutions, analgesics and anesthetics, all of which are in high demand and are integral to serving the needs of disaster victims.

"We are working closely with humanitarian aid agencies to help the people of Haiti obtain access to critical products needed in the provision of medical care," said Christopher B. Begley, chairman and chief executive officer. "The Hospira family expresses deep sympathy to all of the victims of this tragedy, and we will continue to work in the coming weeks and months to provide health and wellness to this devastated region."

In addition to donating products, Hospira has made a total of $200,000 in initial cash grants to the Red Cross and to the company's partners, which include AmeriCares, Direct Relief International, Catholic Medical Mission Board (CMMB) and Project Hope. Hospira also will match employee contributions dollar for dollar up to $50,000 through the Hospira Foundation.

Hospira will continue to monitor disaster relief efforts in Haiti, and will evaluate opportunities to provide additional assistance as further needs and information become available.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at

SOURCE Hospira, Inc.



SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010
2. Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
3. Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers
4. Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings
5. Hospira Reports Third-Quarter 2009 Results
6. Hospira Names Daphne E. Jones Chief Information Officer
7. Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov. 11
8. Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
9. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
10. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
11. PROXY Governance Recommends Against Taros Board and Supports Sun
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from reveals that ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
Breaking Medicine News(10 mins):